Figure 1. Structures of PH and PTB Domains
Ribbon representations of (A) the PLC␦1 PH domain with bound Ins(1,4,5)P 3 (Ferguson et al., 1995a) and (B) the Shc PH/PTB domain with bound NGF receptor (TrkA) phosphopeptide (Zhou et al., 1995) in the same orientation. The bound ligands are colored grey, with their phosphate groups in red. (C) An overlay of the N-terminal pleckstrin PH domain (colored blue) and the Shc PH/PTB domain (colored yellow), illustrating the extent to which the structures of the core backbone regions of the ␤ sandwich are similar (r.m.s. deviation of 1.9 Å ). Figures (B) and (C) were kindly provided by M. Zhou and S. Fesik. The IRS-1 PTB domain is presented in Figure 2 of Eck et al., 1996. of G-proteins (G␤␥) has been reported for several PH domains, most notably that from ␤ARK (Touhara et al., 1994) . Binding to G␤␥ involves only the very C-terminus of the ␤ARK PH domain, together with a large region outside the PH domain, so it is not clear to what extent it is a property of the PH domain itself. Association of intact ␤ARK with G␤␥-containing membranes also requires the presence of phosphatidylinositol(4,5)bisphosphate (PtdInsP 2 ) (Pitcher et al., 1995) . Several other PH domains, notably those from pleckstrin and spectrin, have been shown to bind with low affinity (Kd Ն 30 M) and little apparent stereospecificity to PtdInsP2 in lipid vesicles (Harlan et al., 1994) . The spectrin PH domain also binds weakly (Kd Ն 40 M) to inositol(1,4,5)trisphosphate (InsP3) (Hyvö nen et al., 1995) . The biological relevance of these low affinity, rather nonspecific interactions remains to be established, but it is possible, as in the case of membrane binding by ␤ARK (Pitcher et al., 1995) , that membrane binding could involve the cooperation of several weak, relatively nonspecific interactions.
By contrast with the spectrin and pleckstrin PH domains, the PLC␦ 1 PH domain binds specifically to PtdInsP 2 with relatively high affinity (K d ϭ 1.7 M) (Lemmon et al., 1995) . D-myo inositol(1,4,5)trisphosphate (InsP3) also binds tightly to this PH domain (Kd ϭ 0.21 , 1994) . Whole PLC␦1 binds with high affinity to its substrate, PtdIns(4,5)P 2 (PIP 2 ), permitting processive hydrolysis PtdInsP2-containing vesicles (Rebecchi et al., 1992) . drolyze PtdInsP2 in membranes processively (Rebecchi et al., 1992; Cifuentes et al., 1994) , as is seen for other phospholipases. InsP3, the product of PtdInsP2 hydrolyShc contains two different phosphotyrosine-recogsis by PLC␦1, inhibits the binding of PLC␦1 to PtdInsP2-nizing regions: a C-terminal SH2 domain and a PTB containing membranes, and thus inhibits PLC␦ 1 activity domain at the N-terminus of the molecule. Binding sites by competing for interaction with the PH domain (Cifor the Shc PTB domain are found in several activated fuentes et al., 1994; Yagisawa et al., 1994) . Taken toreceptor tyrosine kinases and comprise the consensus gether, these results suggest that PtdInsP 2 and InsP 3 L/IXNPXpY (Batzer et al., 1995) . Synthetic peptides with are physiologically relevant ligands for the PLC␦ 1 PH this sequence bind specifically, and with high affinity, domain, and that the PH is a regulatory domain controlto the Shc PTB domain (Kavanaugh et al., 1995) . The ling PLC␦1 targeting to substrate-containing membranes IRS-1 PTB domain is adjacent to a PH domain at the as well as product inhibition of the enzyme (Figure 2A) . N-terminus of the molecule. It binds to an NPXpY-conPhosphotyrosine Binding Domains with taining sequence found in the juxtamembrane region of a PH Domain Fold the insulin receptor and shows different specificity from Very recently, a second class of PH domain ligand with the Shc PTB domain (Eck et al., 1996 , and references high affinity and specificity was identified. Structure detherein). The Shc PTB domain structure (Figure 1 ) was termination of the phosphotyrosine binding (PTB) or determined by NMR in complex with an NGF receptor phosphotyrosine interaction (PI) domains (Kavanaugh (TrkA) phosphopeptide (Zhou et al., 1995) . The IRS-1 et al., 1995; Bork and Margolis, 1995) from the adapter PTB domain was determined crystallographically, both proteins Shc (Zhou et al., 1995) and IRS-1 (Eck et al., unliganded and in complex with an insulin receptor 1996) showed them both to be PH domains that had phosphopeptide (Eck et al., 1996) . The PTB domains not previously been identified by sequence homology.
have exactly the same topology as PH domains. Each The two PTB domains themselves share no significant sequence similarity, and are different from SH2 domains.
contains two nearly orthogonal antiparallel ␤ sheets (with 4 and 3 strands, respectively) that form a ␤ sandwich with one corner closed off by an amphipathic C-terminal ␣ helix ( Figure 1 and Figure 2 of Eck et al., 1996) . The backbone structures of core regions of the PTB and PH domains can be superimposed with a rootmean-squared (r.m.s.) deviation of just 1 Å to 1.9 Å ( Figure 1C and Figure 8B of Eck et al., 1996) . Functionally, a feature common to the PH domains of Shc, IRS-1, and PLC␦1 is that their ligands are associated with the cell surface -membrane receptors in the case of Shc and IRS-1, and membrane lipid for PLC␦1. The role of the PH domain in each case is to target the host protein to the cell membrane to facilitate and regulate seen to be important for high affinity NPXpY binding to the Shc and IRS-1 PH domains (Zhou et al., 1995; Eck et al., 1996) as well as InsP 3 binding to the PLC␦ 1 PH (Ferguson et al., 1995a; Ferguson et al., 1995b) . InsP3 domain (where all of the interactions involve phosphate binding to the PLC␦1 PH domain involves variable loops groups) (Ferguson et al., 1995a) . Figure 1A and 1B, to-1, 2, and 3 (Ferguson et al., 1995a) ( Figure 3A ). Using this gether with Figure 4 of Eck et al. (1996) show that, loop designation, the phosphotyrosine of the NPXpY broadly speaking, the two classes of ligand bind on peptide binds to a region of the Shc PH domain involving opposite sides of their cognate domains. However, if basic side-chains of amino acids in both variable loops interactions involving only the phosphotyrosine of the 1 and 3 ( Figure 3B ). Variable loop 1 is particularly long NPXpY peptide with the Shc and IRS-1 PH domains are in the Shc PH domain and extends around the domain considered separately from the rest of the peptide, there allowing residues between ␤1' and ␣2 to interact with pY are some interesting parallels with InsP3 binding to the on a face of the PH domain opposite from that involved in PLC␦1 PH domain. As mentioned above, the ␤1/␤2, ␤3/ InsP 3 binding to the PLC␦ 1 PH domain ( Figure 3B ). The ␤4, and ␤6/␤7 loops are most variable between PH domains, and have been designated variable loops 1 to 3 residues of the IRS-1 PH domain that interact with the Eck, M.J., Dhe-Paganon, S., Trü b, T., Nolte, R.T., and Shoelson, S.E.
pY of the insulin receptor NPXpY peptide are not con- (1996) and Figure 2 of Eck et al., 1996) . gands include various inositol polyphosphates, phosphorylated membrane components, as well as specific protein sequences containing phosphorylated tyrosine, serine, threonine, or histidine residues. It appears unlikely that the low affinity interactions of phosphoinositides described for several PH domains are physiologically relevant. It is difficult to imagine why such a large and diverse family of PH domains (with just 10-15% sequence identity) would exist in order to bind with a similar low affinity to PtdInsP 2 -containing membranes. Rather, we suggest that these interactions represent limited binding to noncognate ligands -the physiologically relevant ligands have yet to be identified. It is likely that many, if not all, PH domains have their own high affinity, cell membrane-associated, ligands and operate according to the paradigms described for the PH domains of PLC␦ 1 and Shc (Figure 2A and 2B) . The structural homology between PH domains might reflect a particularly stable protein scaffold of ␤ sheets that can present variable ligand-binding loops in a manner analogous to that seen in the immunoglobulin superfamily.
